Beyond the lab -- The Geoffrey Beene Cancer Research Center annual retreats continue to promote a vibrant research community at Memorial Sloan Kettering Cancer Center by enhancing the collaboration among different departments across the institution.
Welcome Message -- Charles Sawyers, Chair of the Human Oncology and Pathogenesis Program, opens the annual retreat at Skytop Lodge, in Skytop, Pennsylvania.
Session I: Genomic Approaches to Cancer Gene Discovery -- Michael Berger, Department of Pathology, presents “Targeted DNA Sequencing in Clinical Tumor Specimens for Discovery and Diagnostics.”
Session I: Genomic Approaches to Cancer Gene Discovery -- Craig Thompson, President of Memorial Sloan Kettering Cancer Center, fields questions from audience members.
Retreat Attendees -- Retreat attendees included senior scientists, physicians, junior faculty members, postdoctoral researchers, and graduate students from different departments across the institution.
Audience Members -- Lisa DeAngelis, Chair of the Department of Neurology, during a session presentation
Audience Members -- James Hsieh, Human Oncology and Pathogenesis Program, comments during a session presentation.
Poster Session I -- Postdoctoral researchers discuss their work with fellow trainees.
Outdoors -- Attendees enjoy the trails around the Skytop Lodge during a break from presentations.
Outdoors -- Postdoctoral researchers speak with William Sellers, Vice President and Global Head of Oncology at the Novartis Institute of Biomedical Research, during a break from the presentations.
Geoffrey Beene Cancer Research Center Retreat’s Guest Speaker -- Scott Lowe, Chair of the Geoffrey Beene Cancer Research Center, introduces guest speaker William Sellers and thanks the Geoffrey Beene Foundation for its continued support of the Geoffrey Beene Cancer Research Center at Memorial Sloan Kettering.
Geoffrey Beene Cancer Research Center Retreat’s Guest Speaker -- William Sellers, Vice President and Global Head of Oncology at the Novartis Institute of Biomedical Research, discusses the opportunities and challenges presented by studying the genetic basis of therapy.
Poster Session II -- (From left) Ingo Mellinghoff, of the Human Oncology and Pathogenesis Program, and fellows Owen Clark and Daniel Rohle during the poster session.
Session III: Debate on Drug Development in Academia and Industry -- Ronald DeMatteo, of the Department of Surgery, poses a question to the debaters.
Session III: Debate on Drug Development in Academia and Industry -- Charles Sawyers moderates the debate between William Sellers and Neal Rosen.
Session III: Debate on Drug Development in Academia and Industry -- Milan Chheda, of the Department of Neurology, engages in the conversation during the debate.
Session IV: Cancer Imaging and Therapy -- Michael Evans of Jason Lewis’s laboratory discusses measuring cancer biology in vivo with Zr-89 radiopharmaceuticals.
Session V: Targeting the Ras Pathway -- Maggie Callahan of Jedd Wolchok’s laboratory presents on the rational development of multimodal therapy on melanoma.
Session V: Targeting the Ras Pathway -- James Fagin, of the Human Oncology and Pathogenesis Program, presents on thyroid oncogenesis and MAPK dependence.
Closing Message -- Joan Massagué, Chair of the Cancer Biology and Genetics Program, closes the event by recognizing the efforts of all the scientists at the retreat and thanking the Geoffrey Beene Cancer Research Center for sponsoring the fifth annual retreat.